We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

14 hedge funds and large institutions have $227K invested in NeuroMetrix, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 1314 (+1)

46% less capital invested

Capital invested by funds: $423K → $227K (-$196K)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q3 2023 in Review

14 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2023, worth a combined $227K — down 46% from $423K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NURO positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $22.8K. The largest seller was Vanguard Group, cutting an estimated $113K.

  • 14 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2023, up from 13 in Q2 2023.
  • Funds reported $227K of NeuroMetrix, Inc. Common Stock stock for Q3 2023, down 46% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2023 and 2 closed out, a net change of +1 holder.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $22.8K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2023 was Vanguard Group, an estimated $113K sold.

Based on aggregated 13F filings for Q3 2023.